The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice
Abstract
Loss of MeCP2 (Methyl CpG binding protein 2) in Rett syndrome (RTT) causes brain weight decrease, shrinkage of the cortex with reduced dendritic arborization, behavioral abnormalities, seizures and cardio-respiratory complications. The observed monoamine neurotransmitters reduction in RTT suggested antidepressants as a possible therapy. We treated MeCP2-null mice from postnatal-day 28 for two weeks with desipramine, already tested in RTT, or mirtazapine, an antidepressant with limited side-effects, known to promote GABA release. Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density. Functionally, mirtazapine treatment normalized heart rate, breath rate, anxiety levels and eliminated the hopping behavior observed in MeCP2-null mice, leading to improved phenotypic score. These morphological and functional effects of mirtazapine were accompanied by reestablishment of the GABAergic and glutamatergic receptor activity recorded in cortex and brainstem tissues. Thus, mirtazapine can represent a new potential pharmacological treatment for the Rett syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, in male Mecp2tm1.1Bird null mice, 2 weeks of treatment with Mirtazapine rescued dendritic arborization and spine density of pyramidal neurons and improved phenotypic score [100].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230
A call for transparent reporting to optimize the predictive value of preclinical research
Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., Fillit, H., et al. (2012) · Nature · doi:10.1038/nature11556 · Cited by 1,196
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
Dani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
Kishi, N., & Macklis, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.006 · Cited by 445
Frodl, T., Jäger, M., Smajstrlova, I., Born, C., Bottlender, R., Palladino, T., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0840 · Cited by 279
Research works printed but not linked: 46
- Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185–188 (1999). · DOI · Paper page
- Belichenko, N. P., Belichenko, P. V., Li, H. H., Mobley, W. C. & Francke, U. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. J Comp Neurol 508, 184–195 (2008). · DOI
- Zoghbi, H. Y., Percy, A. K., Glaze, D. G., Butler, I. J. & Riccardi, V. M. Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med 313, 921–924 (1985). · DOI
- Santos, M. et al. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 170, 453–467 (2010). · DOI
- Roux, J. C., Dura, E., Moncla, A., Mancini, J. & Villard, L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci 25, 1915–1922 (2007). · DOI
- Amitai, Y. & Frischer, H. Excess fatality from desipramine in children and adolescents. J Am Acad Child Adolesc Psychiatry 45, 54–60 (2006). · DOI
- Walsh, B. T., Giardina, E. G., Sloan, R. P., Greenhill, L. & Goldfein, J. Effects of desipramine on autonomic control of the heart. J Am Acad Child Adolesc Psychiatry 33, 191–197 (1994). · DOI
- Burrows, G. D. & Kremer, C. M. Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol 17 Suppl 1, 34S–39S (1997). · DOI
- Hartmann, P. M. Mirtazapine: a newer antidepressant. Am Fam Physician 59, 159–161 (1999).
- Borkowska, A., Drozdz, W., Ziolkowska-Kochan, M. & Rybakowski, J. Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. Neuropsychopharmacol Hung 9, 131–136 (2007).
- Stenberg, J. H. et al. More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35, 1080–1086 (2011). · DOI
- Katz, D. M. et al. Preclinical research in Rett syndrome: setting the foundation for translational success. Dis Model Mech 5, 733–745 (2012). · DOI · Paper page
- Lavergne, F., Berlin, I., Gamma, A., Stassen, H. & Angst, J. Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients. Neuropsychiatr Dis Treat 1, 59–68 (2005). · DOI
- Rohdin, M. et al. Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol 37, 338–344 (2007). · DOI
- Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2, 322–328 (2007). · DOI · Paper page
- Samaco, R. C., Hogart, A. & LaSalle, J. M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14, 483–492 (2005). · DOI · Paper page
- Zhang, Z. W., Zak, J. D. & Liu, H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 103, 2470–2481 (2010). · DOI
- Miledi, R., Eusebi, F., Martinez-Torres, A., Palma, E. & Trettel, F. Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc Natl Acad Sci USA 99, 13238–13242 (2002). · DOI
- Bernareggi, A., Duenas, Z., Reyes-Ruiz, J. M., Ruzzier, F. & Miledi, R. Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes. Proc Natl Acad Sci USA 104, 2956–2960 (2007). · DOI
- Yamada, K. A. & Tang, C. M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci 13, 3904–3915 (1993). · DOI · Paper page
- Limon, A., Reyes-Ruiz, J. M. & Miledi, R. Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes. Proc Natl Acad Sci USA 105, 10973–10977 (2008). · DOI
- Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211, 393–396 (1981). · DOI · Paper page
- Belichenko, P. V., Hagberg, B. & Dahlstrom, A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 93, 50–61 (1997). · DOI
- Ruszczycki, B. et al. Sampling issues in quantitative analysis of dendritic spines morphology. BMC Bioinformatics 13, 213 (2012).
- Munchau, A. et al. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 76, 527–533 (2005). · DOI
- Chao, H. T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). · DOI · Paper page
- Blue, M. E., Naidu, S. & Johnston, M. V. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 156, 345–352 (1999). · DOI
- Johnston, M. V., Blue, M. E. & Naidu, S. Rett syndrome and neuronal development. J Child Neurol 20, 759–763 (2005). · doi:10.1177/08830738050200091101
- Roden, W. H., Peugh, L. D. & Jansen, L. A. Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. Neurosci Lett 483, 167–172 (2010). · DOI
- Viemari, J. C. et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25, 11521–11530 (2005). · DOI · Paper page
- Rogoz, Z., Skuza, G. & Legutko, B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. J Physiol Pharmacol 56, 661–671 (2005).
- de Boer, T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 57 Suppl 4, 19–25 (1996).
- Staudacher, I. et al. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn Schmiedebergs Arch Pharmacol 383, 119–139 (2011). · DOI
- Anttila, S. A. & Leinonen, E. V. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7, 249–264 (2001). · DOI · Paper page
- Medrihan, L. et al. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 99, 112–121 (2008). · DOI · Paper page
- Abdala, A. P., Dutschmann, M., Bissonnette, J. M. & Paton, J. F. Correction of respiratory disorders in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 107, 18208–18213 (2010). · DOI · Paper page
- Katz, D. M., Dutschmann, M., Ramirez, J. M. & Hilaire, G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168, 101–108 (2009). · DOI · Paper page
- Rogoz, Z., Wrobel, A., Dlaboga, D., Maj, J. & Dziedzicka-Wasylewska, M. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. J Physiol Pharmacol 53, 105–116 (2002).
- Lee, M. M., Reif, A. & Schmitt, A. G. Major depression: a role for hippocampal neurogenesis? Curr Top Behav Neurosci 14, 153–179 (2013). · DOI
- Devoto, P., Flore, G., Pira, L., Longu, G. & Gessa, G. L. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487, 105–111 (2004). · DOI
- Williams, E. C. et al. Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23, 2968–2980 (2014). · DOI · Paper page
- Calfa, G., Percy, A. K. & Pozzo-Miller, L. Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) 236, 3–19 (2011). · DOI
- Ranjan, A. & Mallick, B. N. A modified method for consistent and reliable Golgi-cox staining in significantly reduced time. Front Neurol 1, 157 (2010). · DOI
- Harris, K. M., Jensen, F. E. & Tsao, B. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation. J Neurosci 12, 2685–2705 (1992). · DOI · Paper page
- Miledi, R., Palma, E. & Eusebi, F. Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies. Methods Mol Biol 322, 347–355 (2006). · DOI
- Miledi, R., Parker, I. & Sumikawa, K. Synthesis of chick brain GABA receptors by frog oocytes. Proc R Soc Lond B Biol Sci 216, 509–515 (1982). · doi:10.1098/rspb.1982.0089
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Janc, O. A., Hüser, M. A., Dietrich, K., Kempkes, B., Menzfeld, C., Hülsmann, S., & Müller, M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00266 · Cited by 35
Metadata
- Authors
- Bittolo, T., Raminelli, C. A., Deiana, C., Baj, G., Vaghi, V., Ferrazzo, S., Bernareggi, A., & Tongiorgi, E.
- Venue
- Scientific Reports
- Published
- 2016-01-25
- Volume
- 6
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 58
- References
- 14
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.